Drupal.behaviors.print = function(context) {window.print();window.close();}>
GATC Subsidiary LifeCodexx to Develop Prenatal Dx Based on Next-Gen Sequencing
May 04, 2010
GATC Subsidiary LifeCodexx to Develop Prenatal Dx Based on Next-Gen Sequencing
The company is currently validating its method for an undisclosed test using clinical samples.
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
LifeCodexx Begins Clinical Validation Study of Sequencing-Based T21 Test
June 29, 2011 / Clinical Sequencing News
Sequencing-Based Fetal Testing Market Heats up as Verinata Plans 2012 Launch for Down Syndrome Dx
May 4, 2011 / Clinical Sequencing News
LifeCodexx Completes Recruitment for Clinical Trial of Trisomy 21 Test
January 10, 2012 / GenomeWeb Daily News
Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
August 17, 2011 / Clinical Sequencing News
Illumina Sees Clinical Applications for MiSeq; Plans FDA Submission in 2012
August 3, 2011 / Clinical Sequencing News